BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26684547)

  • 1. Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes.
    Freire MP; Pierrotti LC; Oshiro IC; Bonazzi PR; Oliveira LM; Machado AS; Van Der Heijden IM; Rossi F; Costa SF; D'Albuquerque LA; Abdala E
    Liver Transpl; 2016 May; 22(5):615-26. PubMed ID: 26684547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?
    Freire MP; Song ATW; Oshiro ICV; Andraus W; D'Albuquerque LAC; Abdala E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115220. PubMed ID: 33045498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients.
    Kim YJ; Kim SI; Lee YD; Choi HJ; Choi JY; Yoon SK; You YK; Kim DG
    Transplant Proc; 2018 May; 50(4):1132-1135. PubMed ID: 29731080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxin use as a risk factor for colonization or infection with polymyxin-resistant Acinetobacter baumannii after liver transplantation.
    Freire MP; Van Der Heijden IM; do Prado GV; Cavalcante LS; Boszczowski I; Bonazzi PR; Rossi F; Guimarães T; D'Albuquerque LA; Costa SF; Abdala E
    Transpl Infect Dis; 2014 Jun; 16(3):369-78. PubMed ID: 24725123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes.
    Freire MP; Oshiro IC; Pierrotti LC; Bonazzi PR; de Oliveira LM; Song AT; Camargo CH; van der Heijden IM; Rossi F; Costa SF; DʼAlbuquerque LA; Abdala E
    Transplantation; 2017 Apr; 101(4):811-820. PubMed ID: 28009779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, mortality, and risk factors associated with carbapenem-resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation.
    Min EK; Yim SH; Choi MC; Lee JG; Joo DJ; Kim MS; Kim DG
    Clin Transplant; 2023 May; 37(5):e14956. PubMed ID: 36860160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation.
    Reddy P; Zembower TR; Ison MG; Baker TA; Stosor V
    Transpl Infect Dis; 2010 Feb; 12(1):87-93. PubMed ID: 19735384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?
    An JH; Kim YH; Moon JE; Jeong JH; Kim SH; Kang SJ; Park KH; Jung SI; Jang HC
    Am J Infect Control; 2017 Jun; 45(6):667-672. PubMed ID: 28242072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study.
    Henig O; Weber G; Hoshen MB; Paul M; German L; Neuberger A; Gluzman I; Berlin A; Shapira C; Balicer RD
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2063-8. PubMed ID: 26205665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients.
    Dadon Z; Ben-Chetrit E; Benjaminov O; Taha L; Wiener-Well Y; Belman D; Levin PD
    Clin Microbiol Infect; 2021 Apr; 27(4):635.e1-635.e4. PubMed ID: 33421579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
    Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
    Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
    Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study.
    Latibeaudiere R; Rosa R; Laowansiri P; Arheart K; Namias N; Munoz-Price LS
    Clin Infect Dis; 2015 Feb; 60(3):415-22. PubMed ID: 25352586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.